BISPECIFIC ANTIBODY mimicking active factor VIII with successive deliveries to Haemophilia Treatment Centers and Related Bleeding Disorders as well as patients' homes; procurement reference: ZZP.ZP.411.100.2026
BISPECYFICZNE PRZECIWCIAŁO naśladujące aktywny czynnik VIII wraz z sukcesywnymi dostawami do Ośrodków Leczenia Hemofilii i Pokrewnych Skaz Krwotocznych oraz domów pacjentów; znak postępowania: ZZP.ZP.411.100.2026
Poland · Warszawa
Contract
BuyerNarodowe Centrum Krwi
TypeSupplies
Estimated valuevalue not published
Published10 August 2026
CategoryMedical equipment & pharma · CPV 33621000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Takeda Pharma Sp. z o. o. | 32 | 2024–2026 |
| MEDIA CHECK POINT Sp. z o. o. | 24 | 2024–2026 |
| Constellation Aneta Piluch | 20 | 2024–2026 |
| CSL Behring sp. z o.o. | 19 | 2024–2026 |
| Asclepios S.A. | 13 | 2024–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
202484
202584
202652
Who knows the rhythm prepares instead of reacting.
6
days until the deadline — Wednesday 26 August at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →